학술논문
A two arm phase II study of FOLFIRI in combination with standard or escalating dose of cetuximab as first line treatment for metastatic colorectal cancer: Everest 2 final results
Document Type
Article
Author
Chiritescu, G.; Dumon, K.; Sagaert, X.; Tejpar, S.; Mercadé, T.M.; Lang, I.; Vivas, C.S.; Papai, Z.; Janssens, J.; Hendrickx, K.; Pracht, M.; Van den Eynde, M.; Taïeb, J.; Moons, V.; Geboes, K.; Van Laethem, J.; Greil, R.; Cervantes, A.; Vergauwe, P.; Ferrante, M.; Vanderstraeten, E.; Fridrik, M.; Wöll, E.; Limón, M.; Rivera, F.; Van Cutsem, E.
Source
In: Annals of oncology : official journal of the European Society for Medical Oncology . (Annals of oncology : official journal of the European Society for Medical Oncology, 1 June 2018, 29:v105)
Subject
Language
English
ISSN
15698041